Talphera (TLPH) Research & Development (2010 - 2026)
Talphera (TLPH) recorded Research & Development of $1.69 million in Q2 2026, up 12.7% from $1.5 million a year earlier and up 2.4% from the prior quarter.
Powered by 
Analysis
Talphera (TLPH) Research & Development (2010 - 2026) Analysis & Trends
On a TTM basis, Talphera's Research & Development came in at $6.7 million as of Jun 30, 2026, up 10.9% year-over-year; for FY2025, it came in at $6.03 million, down 10.2% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 8.5% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $6.72 million in FY2024 (+21.1%), $5.55 million in FY2023 (+66.0%), $3.34 million in FY2022 (-18.4%) and $4.1 million in FY2021 (+1.9%).
- Quarterly Research & Development has ranged from $612,000 in Q4 2022 to $2.05 million in Q3 2024 over the past five years.
- On a year-over-year basis, Research & Development has increased for three consecutive quarters, with growth averaging 8.6% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 189.1% in Q4 2023, against a decline of 43.6% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.65 million (Q1 2026), $1.56 million (Q4 2025) and $1.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.13 Bn | 1,102.72 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.88 Bn | 261.87 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.36 Bn | 235.05 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.80 Bn | 191.20 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.97 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Talphera | 81.57 Mn | 64.49 Mn | - | 1.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2022 | 612,000.00 |
| Sep 30, 2022 | 799,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 836,000.00 |
| Dec 31, 2021 | 986,000.00 |
| Sep 30, 2021 | 1.42 Mn |
API Access
Talphera Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TLPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TLPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TLPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();